You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Drug Price Trends for NDC 00713-0936


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00713-0936

Drug NameNDCPrice/Unit ($)UnitDate
COLESEVELAM 625 MG TABLET 00713-0936-81 0.23766 EACH 2025-02-19
COLESEVELAM 625 MG TABLET 00713-0936-81 0.21945 EACH 2025-01-22
COLESEVELAM 625 MG TABLET 00713-0936-81 0.21673 EACH 2024-12-18
COLESEVELAM 625 MG TABLET 00713-0936-81 0.19503 EACH 2024-11-20
COLESEVELAM 625 MG TABLET 00713-0936-81 0.23001 EACH 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 00713-0936

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 00713-0936

Introduction

The National Drug Code (NDC) 00713-0936 is a unique identifier for a specific pharmaceutical product. To conduct a comprehensive market analysis and price projection for this drug, it is essential to understand the current market trends, pricing dynamics, and regulatory environment.

Understanding the National Drug Code (NDC)

The NDC is a 11-digit code assigned to each drug product by the FDA. It includes the labeler code, product code, and package code. For NDC 00713-0936, the labeler code, product code, and package code must be identified to understand the specific drug and its packaging[5].

Drug Identification

To identify the drug associated with NDC 00713-0936, one would typically refer to the FDA's NDC Directory or other pharmaceutical databases. This directory provides detailed information about the drug, including its name, active ingredients, and pharmacological class[5].

Current Market Trends

The pharmaceutical market is influenced by several factors, including pricing and access to drugs, competition from generics and biosimilars, and regulatory changes.

Pricing and Access

Pricing and access to drugs are significant concerns in the life sciences industry. In the U.S., drug prices are notably higher compared to other countries. For instance, the average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].

Competition from Generics and Biosimilars

Competition from generic drugs and biosimilars is a top trend in the industry. Many high-revenue products are facing patent expirations, which could lead to increased competition and potentially lower prices. This trend is expected to continue, with 37% of life sciences executives viewing competition from generics and biosimilars as a significant issue[3].

Price Analysis

To analyze the prices of the drug associated with NDC 00713-0936, one would need to look at historical pricing data and market trends.

Historical Pricing Data

Historical pricing data can be obtained from databases such as DrugPatentWatch, which provides detailed price trends over time. For example, if we consider another NDC (00378-2245), the price per unit has fluctuated over the past year, indicating market dynamics and potential price adjustments[2].

Market Dynamics

The price of a drug can be influenced by various market dynamics, including supply and demand, regulatory changes, and competition. In the U.S., prices have seen an average increase of 14% between 2017 and 2022, while prices in other regions have decreased[4].

Regulatory Environment

The regulatory environment plays a crucial role in the pricing and availability of pharmaceutical products.

FDA NDC Directory

The FDA's NDC Directory is a critical resource for validating drug information. It includes data on all electronically listed drugs in their final marketed format, including over-the-counter drugs and those with DEA schedules[5].

Open Payments System

For reporting entities, the Drug Name and NDC Reference Data are essential for validating drug information before reporting payments to the Open Payments system. This ensures compliance with regulatory requirements[1].

Price Projections

Price projections for the drug associated with NDC 00713-0936 would involve analyzing current market trends, historical pricing data, and potential regulatory changes.

Impact of Competition

Given the increasing competition from generics and biosimilars, there is a likelihood that prices may decrease or stabilize. This is particularly true if the drug faces patent expiration or increased competition from similar products[3].

Regulatory Changes

Any changes in regulatory policies or reimbursement structures could significantly impact the pricing of pharmaceutical products. For instance, changes in Medicare or Medicaid reimbursement rates can affect the overall market price[4].

Conclusion

The market analysis and price projections for the drug associated with NDC 00713-0936 depend on a thorough understanding of current market trends, historical pricing data, and the regulatory environment.

  • Pricing Trends: The U.S. market is characterized by high drug prices compared to other regions, with an average price increase of 14% between 2017 and 2022.
  • Competition: Increased competition from generics and biosimilars is expected to impact pricing.
  • Regulatory Environment: Compliance with FDA regulations and reporting requirements is crucial.
  • Market Dynamics: Supply and demand, as well as regulatory changes, will influence future prices.

Key Takeaways

  • High U.S. Prices: Drug prices in the U.S. are significantly higher than in other regions.
  • Competition Impact: Generics and biosimilars are likely to affect pricing.
  • Regulatory Compliance: Adherence to FDA and Open Payments system requirements is essential.
  • Market Dynamics: Supply, demand, and regulatory changes will shape future prices.

FAQs

Q: What is the National Drug Code (NDC) and its significance? A: The NDC is an 11-digit code assigned by the FDA to each drug product, helping in the identification and tracking of pharmaceuticals.

Q: How do generic drugs and biosimilars affect the pharmaceutical market? A: Generic drugs and biosimilars increase competition, potentially leading to lower prices and affecting the market strategies of pharmaceutical companies.

Q: Why are drug prices in the U.S. higher than in other countries? A: Drug prices in the U.S. are higher due to a combination of factors including higher prices for the same drugs and a drug mix that skews towards more expensive compounds[4].

Q: What role does the FDA's NDC Directory play in the pharmaceutical industry? A: The FDA's NDC Directory is a critical resource for validating drug information, including data on all electronically listed drugs in their final marketed format[5].

Q: How do regulatory changes impact the pricing of pharmaceutical products? A: Regulatory changes, such as those in reimbursement rates or patent laws, can significantly affect the pricing and availability of pharmaceutical products.

Sources

  1. CMS - Drug Name and National Drug Code (NDC) Reference Data Instructions Calendar Year 2024
  2. DrugPatentWatch - Latest drug prices and trends for NDC 00378-2245
  3. Deloitte Insights - 2025 life sciences outlook
  4. ASPE - ISSUE BRIEF - International Market Size and Prices
  5. YouTube - NDC Directory (March 2015)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.